Showing 12,301 - 12,320 results of 106,627 for search '(( 5 ((ng decrease) OR (a decrease)) ) OR ( 50 ((we decrease) OR (mean decrease)) ))', query time: 1.17s Refine Results
  1. 12301

    Data Sheet 1_Prognostic impact of miR-17-5p and miR-20a-5p in NSCLC diverge in subgroups according to lymph node status.docx by Dagny Førde (20452325)

    Published 2025
    “…Overexpression of miR-20a-5p led to decreased proliferation in one of two investigated cell lines and, like miR-17-5p, increased invasion.…”
  2. 12302
  3. 12303
  4. 12304

    Solid State and Aqueous Solution Characterization of Rectangular Tetranuclear V<sup>IV/V</sup>-<i>p</i>-Semiquinonate/Hydroquinonate Complexes Exhibiting a Proton Induced Electron... by Chryssoula Drouza (1406464)

    Published 2008
    “…Reaction of the non-innocent dinucleating ligand 2,5-bis[N,N-bis(carboxymethyl) aminomethyl]hydroquinone (H<sub>6</sub>bicah) with VO<sup>2+</sup> and VO<sub>4</sub><sup>3−</sup> salts in water in the pH range 2 to 4.5 provides a series of novel tetranuclear V<sup>IV</sup> and/or V<sup>V</sup> macrocycles with the main core consisting of the anions [V<sup>V</sup><sub>4</sub>O<sub>4</sub>(μ-O)<sub>2</sub>(μ-bicah)<sub>2</sub>]<sup>4−</sup> isolated at pH = 2.5 and [V<sup>IV</sup><sub>2</sub>V<sup>V</sup><sub>2</sub>O<sub>4</sub>(μ-O)<sub>2</sub>(μ-bicas)(μ-bicah)]<sup>5−</sup> and [V<sup>IV</sup><sub>4</sub>O<sub>4</sub>(μ-O)<sub>2</sub>(μ-bicas)<sub>2</sub>]<sup>6−</sup> isolated at pH = 4.5 (bicas<sup>•5−</sup> = 2,5-bis[N,N-bis(carboxymethyl) aminomethyl]-<i>p</i>-semiquinonate), whereas at pH = 2 the dinuclear [(V<sup>IV</sup>O)<sub>2</sub>(OH<sub>2</sub>)<sub>2</sub>(μ-bicah)]<sup>2−</sup> was obtained. …”
  5. 12305
  6. 12306

    Re-evaluation of a Tn<i>5</i>::<i>gacA</i> mutant of <i>Pseudomonas syringae</i> pv. <i>tomato</i> DC3000 uncovers roles for <i>uvrC</i> and <i>anmK</i> in promoting virulence by Megan R. O’Malley (7485323)

    Published 2019
    “…We recently investigated the virulence defect of strain AC811, a Tn<i>5</i>::<i>gacA</i> mutant of <i>P</i>. <i>syringa</i>e pv. …”
  7. 12307
  8. 12308

    Development and characterization of a bivalent mRNA vaccine targeting the Delta and Omicron variants of SARS-CoV-2 by Xiao-Chuan Xiong (22337097)

    Published 2025
    “…Then, the immunogenicity of the vaccine candidates under a two-dose prime immunization regimen were further analyzed, demonstrating that ARCoV-Biv induced a broad neutralizing antibody response, with mean neutralization titers (NT50) of 87,556.33 against Delta (B.1.617.2) and 52,634.67 against Omicron BA.1, representing 71.19-fold and 399.72-fold increases, respectively, compared to the levels prior to booster immunization. …”
  9. 12309

    DataSheet_1_A Long Noncoding RNA, GAS5 Can Be a Biomarker for Docetaxel Response in Castration Resistant Prostate Cancer.docx by Yuting Shan (10841241)

    Published 2021
    “…Here, we test the hypothesis that the expression of a lncRNA, grow arrest-specific 5 (GAS5) can be a biomarker for docetaxel response in castration resistant prostate cancer (CRPC) using both prostate cancer (PCa) cell lines and CRPC patient datasets. …”
  10. 12310

    ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type by Luca Schifanella (6694940)

    Published 2019
    “…High Alum dosage, in contrast, elicited serum IgG to V2 that correlated with a decreased risk of Tier 1 SHIV-C acquisition. …”
  11. 12311
  12. 12312
  13. 12313

    Data_Sheet_1_The domestication of SARS-CoV-2 into a seasonal infection by viral variants.xlsx by Ryley D. McClelland (17678247)

    Published 2023
    “…We observed a decrease in COVID-19 disease severity surrogates after the arrival of the Delta variant, coinciding with significantly smaller plaque sizes. …”
  14. 12314
  15. 12315
  16. 12316
  17. 12317

    Reply to Jüni and colleagues regarding “Converting standardized mean differences to dichotomous outcomes: A comment on the Cochrane review ‘Intra-articular corticosteroid for knee... by Martin Mayer (6509486)

    Published 2019
    “…As I noted previously, I submit the following in a spirit of collegial collaboration.</p> <p> </p> <p>They agree with my first point regarding the assumed probability of achieving ≥50% improvement in function in the control group, and they provide a corrected probability in line with my previous correspondence (i.e., they correct the probability from 26% as they used previously[1,3,5–7] to 22% as noted in my previous correspondence[2,4]). …”
  18. 12318

    The effect of normobaric oxygen in patients with acute stroke: a systematic review and meta-analysis by Jiayue Ding (4689559)

    Published 2018
    “…Data from prospective studies were processed using RevMan5.0 software, provided by Cochrane collaboration and transformed using relevant formulas.…”
  19. 12319
  20. 12320

    Image_5_COVID-19 Pandemic and Trends in Clinical Trials: A Multi-Region and Global Perspective.TIF by Satoshi Nishiwaki (560641)

    Published 2021
    “…The activity of clinical trials was decreased as the number of COVID-19 patients was increased, and a statistically negative correlation was observed between the prevalence of COVID-19 and the percentage decrease in the number of clinical trials stared or reported results. …”